Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of Insmed Inc (NASDAQ: INSM) was $186.88 for the day, up 2.25% from the previous closing price of $182.77. In other words, the price has increased by $2.25 from its previous closing price. On the day, 1.63 million shares were traded. INSM stock price reached its highest trading level at $189.305 during the session, while it also had its lowest trading level at $182.09.
Ratios:
Our analysis of INSM’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.34 and its Current Ratio is at 4.63. In the meantime, Its Debt-to-Equity ratio is 0.79 whereas as Long-Term Debt/Eq ratio is at 0.77.
On October 20, 2025, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $171.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 03 ’25 when Smith Michael Alexander sold 27,130 shares for $183.78 per share. The transaction valued at 4,985,911 led to the insider holds 54,902 shares of the business.
Michael A Smith bought 27,130 shares of INSM for $4,985,054 on Nov 03 ’25. On Sep 12 ’25, another insider, Schaeffer Orlov S Nicole, who serves as the Chief People Strategy Officer of the company, sold 76,520 shares for $145.45 each. As a result, the insider received 11,129,927 and left with 36,461 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSM now has a Market Capitalization of 39856545792 and an Enterprise Value of 38916694016. For the stock, the TTM Price-to-Sale (P/S) ratio is 89.16 while its Price-to-Book (P/B) ratio in mrq is 42.01. Its current Enterprise Value per Revenue stands at 87.058 whereas that against EBITDA is -39.76.
Stock Price History:
The Beta on a monthly basis for INSM is 1.03, which has changed by 1.549449 over the last 52 weeks, in comparison to a change of 0.13367426 over the same period for the S&P500. Over the past 52 weeks, INSM has reached a high of $197.08, while it has fallen to a 52-week low of $60.40. The 50-Day Moving Average of the stock is 20.41%, while the 200-Day Moving Average is calculated to be 80.81%.
Shares Statistics:
INSM traded an average of 2.47M shares per day over the past three months and 2644500 shares per day over the past ten days. A total of 212.58M shares are outstanding, with a floating share count of 209.13M. Insiders hold about 1.94% of the company’s shares, while institutions hold 97.84% stake in the company. Shares short for INSM as of 1760486400 were 9481459 with a Short Ratio of 3.84, compared to 1757894400 on 10575467. Therefore, it implies a Short% of Shares Outstanding of 9481459 and a Short% of Float of 4.9399999999999995.
Earnings Estimates
The company has 13.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$1.32, with high estimates of -$0.88 and low estimates of -$1.63.
Analysts are recommending an EPS of between -$4.97 and -$6.76 for the fiscal current year, implying an average EPS of -$6.11. EPS for the following year is -$3.72, with 13.0 analysts recommending between -$2.53 and -$5.23.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 17 analysts. It ranges from a high estimate of $214.8M to a low estimate of $135M. As of. The current estimate, Insmed Inc’s year-ago sales were $104.44MFor the next quarter, 17 analysts are estimating revenue of $194.66M. There is a high estimate of $231M for the next quarter, whereas the lowest estimate is $169.96M.
A total of 18 analysts have provided revenue estimates for INSM’s current fiscal year. The highest revenue estimate was $540.48M, while the lowest revenue estimate was $445.8M, resulting in an average revenue estimate of $503.88M. In the same quarter a year ago, actual revenue was $363.71MBased on 17 analysts’ estimates, the company’s revenue will be $1.19B in the next fiscal year. The high estimate is $1.49B and the low estimate is $968.93M.
